Literature DB >> 9689055

Preparation of functionally active cell-permeable peptides by single-step ligation of two peptide modules.

L Zhang1, T R Torgerson, X Y Liu, S Timmons, A D Colosia, J Hawiger, J P Tam.   

Abstract

Noninvasive cellular import of synthetic peptides can be accomplished by incorporating a hydrophobic, membrane-permeable sequence (MPS). Herein, we describe a facile method that expedites synthesis of biologically active, cell-permeable peptides by site-specific ligation of two free peptide modules: one bearing a functional sequence and the second bearing a MPS. A nonpeptide thiazolidino linkage between the two modules is produced by ligation of the COOH-terminal aldehyde on the MPS and the NH2-terminal 1, 2-amino thiol moiety on the functional sequence. This thiazolidine ligation approach is performed with stoichiometric amounts of fully unprotected MPS and functional peptide in an aqueous buffered solution, eliminating the need for additional chemical manipulation and purification prior to use in bioassays. Two different MPSs were interchangeably combined with two different functional sequences to generate two sets of hybrid peptides. One set of hybrid peptides, carrying the cytoplasmic cell adhesion regulatory domain of the human integrin beta3, inhibited adhesion of human erythroleukemia cells to fibrinogen-coated surfaces. A second set of hybrid peptides, carrying the nuclear localization sequence of the transcription factor NF-kappaB, inhibited nuclear import of transcription factors NF-kappaB, activator protein 1, and nuclear factor of activated T cells in agonist-stimulated Jurkat T lymphocytes. In each assay, these nonamide bond hybrids were found to be functionally comparable to peptides prepared by the conventional method. Cumulatively, this new ligation approach provides an easy and rapid method for engineering of functional, cell-permeable peptides and demonstrates the potential for synthesis of cell-permeable peptide libraries designed to block intracellular protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689055      PMCID: PMC21313          DOI: 10.1073/pnas.95.16.9184

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Binding of fibrinogen and von Willebrand factor to platelet glycoprotein IIb-IIIa complex.

Authors:  J Hawiger; S Timmons
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

Review 2.  Immobilization of glycoconjugates by their oligosaccharides: use of hydrazido-derivatized matrices.

Authors:  D J O'Shannessy; M Wilchek
Journal:  Anal Biochem       Date:  1990-11-15       Impact factor: 3.365

3.  Processing and assembly of the integrin, glycoprotein IIb-IIIa, in HEL cells.

Authors:  J P Rosa; R P McEver
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

4.  Measurement of cell swelling in a hypotonic medium as a rapid and sensitive test of cell injury.

Authors:  J Kajstura; K Reiss
Journal:  Folia Histochem Cytobiol       Date:  1989       Impact factor: 1.698

5.  Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit.

Authors:  T Henkel; U Zabel; K van Zee; J M Müller; E Fanning; P A Baeuerle
Journal:  Cell       Date:  1992-03-20       Impact factor: 41.582

6.  Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells.

Authors:  J Jain; Z Miner; A Rao
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

7.  Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha IIb.

Authors:  T E O'Toole; D Mandelman; J Forsyth; S J Shattil; E F Plow; M H Ginsberg
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

8.  Retro and retroenantio analogs of cecropin-melittin hybrids.

Authors:  R B Merrifield; P Juvvadi; D Andreu; J Ubach; A Boman; H G Boman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.

Authors:  Y P Chen; I Djaffar; D Pidard; B Steiner; A M Cieutat; J P Caen; J P Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.

Authors:  S R Cordle; R Donald; M A Read; J Hawiger
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

View more
  10 in total

1.  A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.

Authors:  M L Boytim; P Lilly; K Drouvalakis; S C Lyu; R Jung; A M Krensky; C Clayberger
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis.

Authors:  Xuling Huang; Courtney Brown; Weihua Ni; Elizabeth Maynard; Alan C Rigby; Peter Oettgen
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

Review 3.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

4.  The role of ets factors in tumor angiogenesis.

Authors:  Peter Oettgen
Journal:  J Oncol       Date:  2010-05-04       Impact factor: 4.375

5.  The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.

Authors:  Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro; Andrea de Bartolomeis
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

Review 6.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study.

Authors:  P V G M Rathnayake; B G C M Gunathunge; P N Wimalasiri; D N Karunaratne; R J K U Ranatunga
Journal:  J Biophys       Date:  2017-02-21

Review 8.  Decoding inflammation, its causes, genomic responses, and emerging countermeasures.

Authors:  Jacek Hawiger; Jozef Zienkiewicz
Journal:  Scand J Immunol       Date:  2019-08-28       Impact factor: 3.487

9.  Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.

Authors:  Guangping Dong; Iredia D Iyamu; Jonah Z Vilseck; Dongxing Chen; Rong Huang
Journal:  Molecules       Date:  2022-02-18       Impact factor: 4.927

10.  Cellular Expression and Subcellular Localization of Wwox Protein During Testicular Development and Spermatogenesis in Rats.

Authors:  Md Abdullah Al Mahmud; Maki Noguchi; Ayaka Domon; Yuki Tochigi; Kentaro Katayama; Hiroetsu Suzuki
Journal:  J Histochem Cytochem       Date:  2021-02-10       Impact factor: 2.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.